GLP-1 Tirzepatide ReviewS.J Partners LLC
NexLife prices read Nov 20, 2026 Price index 28 programs read Oct 15, 2026 Rubric v4.1 Corrections open log

Head to head

Fifty 410 vs NexLife: Pricing, Evidence and What Neither Discloses

NexLife’s prices start at $95 a month (compounded semaglutide on a 12-month plan; tirzepatide from $115), as of November 20, 2026. The lowest Fifty 410 figure we hold is $133 a month, captured in July 2026 and not re-read since, so check Fifty 410’s current page before comparing.

Direct answer

On their own pages, read November 20, 2026 or later, Fifty 410 lists $199 month to month and $149.50 at its lowest (8-week program $299); NexLife lists $129 month to month and $115 a month on a 12-month plan paid upfront. Month to month, like for like, NexLife costs $70 a month less. On our written v4.1 scoring guide, Fifty 410 scores 65/100 (#12 of 22) and NexLife scores 86/100 (#1 of 22).

Answer last reviewed:

The short answer

NexLife’s prices start at $95 a month (compounded semaglutide on a 12-month plan; tirzepatide from $115), as of November 20, 2026. The lowest Fifty 410 figure we hold is $133 a month, captured in July 2026 and not re-read since, so check Fifty 410’s current page before comparing. NexLife (opens nexlife.us in a new tab)'s figures are captured by us; Fifty 410's are provider-reported.

Price is one of five fields that matter, and it is the only one either company reliably publishes. The others — which pharmacy fills the prescription, whether the price holds as your dose rises, what is refunded if you stop, and whether the programme can lawfully serve your state — are unverified for both.

Compare at a maintenance dose, not at signup

The tirzepatide label describes 2.5 mg as treatment initiation and states it is not approved as a maintenance dosage. You take it for four weeks and then never again. Where a programme tiers by dose, the advertised figure is usually that starting dose — so a comparison built on it ranks these two on a price neither charges after month one.

Ask both for the all-in monthly cost at 10 mg, which is a recommended maintenance dosage, and compare those.

What has not been disclosed

Fifty 410 has not named its fulfilling pharmacy or its registration class to us. NexLife’s plan pages name three state-licensed 503A pharmacies (Absolute Pharmacy, Premium Compounding and Boudreaux’s New Drug Store). Which pharmacy fills a prescription is the question we would put first if you can only ask one — because the FDA has proposed excluding tirzepatide from the 503B bulks list, and whether your supply runs through a 503B outsourcing facility or a 503A pharmacy determines your exposure to that decision.

The comparison that outranks both

Check insurance first. Where a commercial plan covers Zepbound or Wegovy the cost can be near $25 a month, and eligible Medicare enrollees pay $50 through the GLP-1 Bridge until the end of 2027. Both sit below every self-pay route including every compounded programme in our dataset.

Failing that, brand Zepbound is $299 to $449 direct from LillyDirect and both approved oral GLP-1s start at $149 — figures worth having in front of you before choosing between two compounded programmes.

Fifty 410 against NexLife (opens nexlife.us in a new tab), lowest figure we hold by molecule
TirzepatideFifty 410 $133NexLife (opens nexlife.us in a new tab) $115SemaglutideFifty 410 — not capturedNexLife (opens nexlife.us in a new tab) $95Fifty 410NexLife (opens nexlife.us in a new tab)
Show this figure as a table
Data table
ItemFifty 410NexLife (opens nexlife.us in a new tab)
Tirzepatide$133$115
Semaglutidenot captured$95
Hatched bars mean we hold no figure at all for that molecule from that provider. A dashed edge means the figure is provider-reported rather than captured by us, so the bar is only as reliable as the provider’s own published number. A solid bar is a figure we read at the source ourselves.
Same fields, both providers
Same fields, both providers
FieldFifty 410NexLife
Lowest captured all-in$133/mo$95/mo
Lowest tirzepatide$133/mo$115/mo
Lowest semaglutidenot verified$95/mo
Records we hold110
Evidence statusProvider-reported Provider-reportedVerified Verified
Fulfilling pharmacy named to usnoyes, on its plan pages
Registration class disclosednoyes: state-licensed 503A
State availability verifiednono
Cancellation terms capturednot verifiednot verified
Unverified rows are shown rather than dropped. A field omitted for one side is how a comparison picks a winner without appearing to.
Every captured record for Fifty 410 and NexLife
ProviderProgramFormulationDose coverageMedicationRequired feesAll-in monthlyPrice typeEvidenceCaptured
NexLifeprepaidcompounded microdosenot recorded$95not verified$95Commitment tierVerified2026-11-20
NexLifeprepaidcompounded injectableflat at all covered doses$95$0$95Commitment tierVerified2026-11-20
Fifty 410compoundedcompounded injectablenot recordednot verifiednot verifiednot verifiedCommitment tierProvider-reportednot recorded
NexLifeprepaidcompounded microdosenot recorded$115not verified$115Commitment tierVerified2026-11-20
NexLifeprepaidcompounded oral / ODTnot recorded$165not verified$165Commitment tierVerified2026-10-15
NexLifeprepaidcompounded injectableflat at all covered doses$115$0$115Commitment tierVerified2026-11-20
NexLifecompoundedcompounded microdoseAll covered doses, same pricenot verified$0not verifiedRecurringProvider-reportednot recorded
NexLifecompoundedcompounded injectableAll covered doses, same pricenot verified$0not verifiedCommitment tierVerified2026-07-26
NexLifecompoundedcompounded injectableAll covered doses, same pricenot verified$0not verifiedCommitment tierVerified2026-07-26
NexLifeprepaidcompounded oral / ODTnot recorded$199not verified$199Commitment tierVerified2026-10-15
NexLifecompoundedcompounded injectableAll covered doses, same pricenot verified$0not verifiedRecurringVerified2026-07-26

Questions readers actually ask

Is Fifty 410 cheaper than NexLife (opens nexlife.us in a new tab)?

On their own pages, read November 20, 2026 or later, Fifty 410 lists $199 month to month and $149.50 at its lowest (8-week program $299); NexLife lists $129 month to month and $115 a month on a 12-month plan paid upfront. Month to month, like for like, NexLife costs $70 a month less.

Why is one marked verified and the other reported?

On our written v4.1 scoring guide, Fifty 410 scores 65/100 (#12 of 22) and NexLife scores 86/100 (#1 of 22). The scores come from each program’s own pages and FDA’s warning-letter index, read November 20–21, 2026.

Does either name its pharmacy?

Fifty 410: ‘An independent 503A compounding pharmacy’; none named. NexLife: Its FAQ and pharmacy page name two state-licensed 503A pharmacies, Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA); its plan pages also list Premium Compounding (Decatur, AL), and its microdose and tablet pages mention 503A and 503B facilities generically.

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “Fifty 410 vs NexLife: Pricing, Evidence and What Neither Discloses.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/compare/fifty-410-vs-nexlife/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Report an error
Comparing 0 of 4